Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Substance Name: Dronabinol
Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro.
Diagnostic Ability of a Linear Discriminant Function for Spectral-Domain Optical Coherence Tomography in Patients with Multiple Sclerosis.
Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral Doses.
Mechanism for p38α-mediated experimental autoimmune encephalomyelitis.
FDA approves clinical trial of TDI-132 (Gilenya) in ALS patients
Quantitative structure-activity relationship studies on sulfonamide-based MMP inhibitors.
The attributable burden of panic disorder in the impairment of quality of life in a national survey in Italy.
Risk of vascular disease in patients with multiple sclerosis: a review.
Contribution of imaging to the diagnosis of optic neuropathies.
Cannabinoid pharmacology: the first 66 years.
Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination.
Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis.
Neuromuscular taping in multiple sclerosis. A pilot study.
Assessing the potential impact of non-proprietary drug copies on quality of medicine and treatment in patients with relapsing multiple sclerosis: the experience with fingolimod.
Neurorehabilitation for other neurologic disorders.
No excess of mitochondrial DNA deletions within muscle in progressive multiple sclerosis.
Clinical spectrum of CNS aquaporin-4 autoimmunity.
Subclinical CNS Inflammation as Response to a Myelin Antigen in Humanized Mice.
Can we overcome the 'clinico-radiological paradox' in multiple sclerosis?
Fampridine – Benefit assessment according to § 35a Social Code Book V
Intraventricularly injected Olig2-NSCs attenuate established relapsing-remitting EAE in mice.
FTY720, sphingosine 1-phosphate receptor modulator, selectively radioprotects hippocampal neural stem cells.
The diagnosis and management of lower urinary tract symptoms in multiple sclerosis patients.
The next generation of exoskeletons: lighter, cheaper devices are in the works.

Pages